You have 9 free searches left this month | for more free features.

tki

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oligometastatic Disease, NSCLC, Driver Mutation Trial in Mumbai (Local Consolidative Radiation Therapy, TKI)

Recruiting
  • Oligometastatic Disease
  • +2 more
  • Local Consolidative Radiation Therapy
  • TKI
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Mar 11, 2022

Withdrawal of Second-generation Tyrosine Kinase Inhibitors After

Recruiting
  • MMR on 12 Month
  • TKI
  • Guangzhou, Guangdong, China
  • +1 more
Apr 21, 2022

Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 22, 2021

Stage IV NSCLC Trial in Wuhan (SBRT+TKI, TKI)

Completed
  • Stage IV Non-small Cell Lung Cancer
  • SBRT+TKI
  • TKI
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College of Huazhong University
Apr 5, 2021

Hepatocellular Carcinoma Trial in Guangzhou, Kaiping (HAIC of 130 mg/m² Oxaliplatin, and 5-fu, HAIC of 85 mg/m² Oxaliplatin, and

Recruiting
  • Hepatocellular Carcinoma
  • HAIC of 130 mg/m² Oxaliplatin, and 5-fu
  • +2 more
  • Guangzhou, Guangdong, China
  • +2 more
Jan 12, 2021

NSCLC Trial in United Kingdom (SBRT, TKI)

Unknown status
  • NSCLC
  • SBRT
  • TKI
  • Sutton, England, United Kingdom
  • +5 more
Oct 19, 2018

Non-Small Cell Adenocarcinoma, Tyrosine Kinase Mutation, EGFR Gene Mutation Trial in Mexico (Metformin, TKI)

Unknown status
  • Non-Small Cell Adenocarcinoma
  • +2 more
  • Mexico, Mexico
    Instituto National de Cancerologia
Mar 1, 2017

Lung Adenocarcinoma Trial in Hangzhou (TKI, Thoracic Hypofractionated Radiotherapy, Thymosin Alpha 1)

Unknown status
  • Lung Adenocarcinoma
  • TKI
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Nov 23, 2016